Epirubicin in non-Hodgkinʼs lymphomas
Massimo Lopez(Catholic University of America), Nicola Di Pietro, Paola Papaldo(Cancer Institute (WIA)), Carlo Federico Perno(Centre International De Reference Chantal Biya), Luigi Di Lauro, Fabrizio Ganzina(Ospedale San Carlo)
Cited by 11
Related Papers
Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: an open-label, 2 × 2 factorial, randomised phase 3 trial
|The Lancet|2015|202
Phase III randomized study of fluorouracil, epirubicin, and cyclophosphamide v fluorouracil, doxorubicin, and cyclophosphamide in advanced breast cancer: an Italian multicentre trial. Italian Multicentre Breast Study with Epirubicin.
|Journal of Clinical Oncology|1988|168
Lonidamine: Efficacy and safety in clinical trials for thetreatment of solid tumors
|Drugs of today|2003|168
Clinical outcome of patients with brain metastases from HER2-positive breast cancer treated with lapatinib and capecitabine
|Annals of Oncology|2010|168
Randomized Phase II Trial of weekly paclitaxel alone versus trastuzumab plus weekly paclitaxel as first-line therapy of patients with Her-2 positive advanced breast cancer
|Breast Cancer Research and Treatment|2006|140